Weill Medical College Of Cornell University
Clinical trials sponsored by Weill Medical College Of Cornell University, explained in plain language.
-
New antibiotic strategy targets deadly infections in vulnerable patients
Disease control TerminatedThis study tested whether the antibiotic ceftolozane-tazobactam can effectively treat serious Pseudomonas aeruginosa infections in people with blood cancers or those who had a stem cell transplant. Participants received the drug through a vein every 8 hours for 10 to 14 days. Res…
Phase: PHASE4 • Sponsor: Weill Medical College of Cornell University • Aim: Disease control
Last updated Jun 15, 2026 19:06 UTC
-
Targeted drug trial for Hard-to-Treat prostate cancer stalls early
Disease control TerminatedThis study tested the drug cabozantinib in men with a type of advanced prostate cancer that no longer responds to hormone therapy. It focused on patients whose tumors had certain gene changes or had spread to the liver. The trial was stopped early after enrolling only 4 people, s…
Phase: PHASE2 • Sponsor: Weill Medical College of Cornell University • Aim: Disease control
Last updated Jun 10, 2026 13:29 UTC
-
Targeted brain chemotherapy for rare tumors shows promise but study halted
Disease control TerminatedThis study looked at giving chemotherapy directly into the arteries of the brain to treat rare tumors called atypical choroid plexus papilloma and choroid plexus carcinoma. The goal was to shrink the tumors before a second surgery. Only one person enrolled, and the study was stop…
Phase: PHASE1 • Sponsor: Weill Medical College of Cornell University • Aim: Disease control
Last updated Jun 09, 2026 12:10 UTC
-
New combo therapy for tough lymphoma shows early promise
Disease control TerminatedThis early-phase trial tested a combination of two oral drugs, tazemetostat and venetoclax, in people with Non-Hodgkin lymphoma that came back or didn't respond to treatment. The main goals were to find the safest dose and see what side effects occur. Only 3 people took part befo…
Phase: PHASE1 • Sponsor: Weill Medical College of Cornell University • Aim: Disease control
Last updated Jun 08, 2026 13:12 UTC
-
Fewer radiation sessions may be just as tolerable for prostate cancer
Symptom relief TerminatedThis study looked at whether giving only 2 MRI-guided radiation treatments is as gentle on the body as 5 treatments for men with low or intermediate-risk prostate cancer. The main goal was to see if the shorter course caused similar or fewer bowel and urinary side effects over tw…
Phase: PHASE2 • Sponsor: Weill Medical College of Cornell University • Aim: Symptom relief
Last updated Jun 15, 2026 19:08 UTC